Atea Pharmaceuticals, Inc. (AVIR)

4.65 -0.09 (-1.90%) USD  |  NASDAQ  |  Feb 20, 16:00
4.645 0.00 (0.00%) After-Hours: 20:00
More

Atea Pharmaceuticals Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
Aclaris Therapeutics, Inc. Upgrade
PMV Pharmaceuticals, Inc. Upgrade
Instil Bio, Inc. Upgrade
Coya Therapeutics, Inc. Upgrade